Pituitary autoantibodies in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)

Area of Science:

• Endocrinology
• Immunology
• Genetics

Background:

• Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is an autosomal recessive disorder caused by AIRE gene mutations.
• The involvement of pituitary autoimmunity in APECED pathogenesis remains unclear.
• This study investigates the prevalence and significance of pituitary autoantibodies in APECED patients.

Discussion:

• A high prevalence (58%) of autoantibodies against human pituitary enolase was observed in APECED patients.
• Pituitary autoantibodies were significantly more common in APECED patients than in controls.
• Seroconversion occurred between ages 10-53, with sustained positivity in most patients.

Key Insights:

• Autoantibodies to pituitary enolase are prevalent markers of neuroendocrine autoimmunity in APECED.
• The presence of pituitary autoantibodies does not correlate with clinical hypopituitarism in this cohort.
• Anti-candidal enolase antibodies may precede or coincide with pituitary autoantibody development.

Outlook:

• Further research is needed to elucidate the precise role of pituitary autoimmunity in APECED.
• Investigating the clinical implications of other detected pituitary autoantibody reactivities is warranted.
• Understanding the mechanisms linking AIRE mutations to pituitary autoimmunity could reveal new therapeutic targets.